Cargando…
A framework for the in vitro evaluation of cancer-relevant molecular characteristics and mitogenic potency of insulin analogues
Epidemiological and laboratory studies raise the possibility of a link between clinically prescribed insulin analogues and increased cancer risk. Accordingly, there is a regulatory mandate for cancer-related pre-clinical safety evaluation during insulin analogue development, but currently, there is...
Autores principales: | Baricevic, Ivona, Jones, David R., Roberts, Darren L., Lutzen, Anne, Lundby, Anders, Worm, Jesper, Hansen, Bo F., Renehan, Andrew G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552242/ https://www.ncbi.nlm.nih.gov/pubmed/26026165 http://dx.doi.org/10.1093/carcin/bgv071 |
Ejemplares similares
-
Systematic Evaluation of the Metabolic to Mitogenic Potency Ratio for B10-Substituted Insulin Analogues
por: Glendorf, Tine, et al.
Publicado: (2012) -
Minimizing Mitogenic Potency of Insulin Analogues Through Modification of a Disulfide Bond
por: Ong, Shee Chee, et al.
Publicado: (2022) -
Molecular Characterisation of Long-Acting Insulin Analogues in Comparison with Human Insulin, IGF-1 and Insulin X10
por: Hansen, Bo F., et al.
Publicado: (2012) -
The metabolic and mitogenic properties of basal insulin analogues
por: Tennagels, Norbert, et al.
Publicado: (2013) -
Connectivity and Order: an Analytical Framework
por: Gaens, Bart, et al.
Publicado: (2023)